.Observing a poor presenting for Lykos Rehabs' MDMA candidate for post-traumatic stress disorder at ...
.AN2 Rehabs is rethinking its own company in reaction to poor midphase information, pledging to give...
.Merck & Co. is spending $700 million ahead of time to challenge Amgen in a blood cancer market. ...
.With Gilead Sciences about to an FDA selection for its own liver disease medicine seladelpar, the c...
.CEO David Ricks can easily find the providers establishing outdoors tents at basecamp responsible f...
.Cushion Liquidators has actually switched Entero Rehabs white as a piece. The creditor bought Enter...
.Exelixis is surrendering on its own tissue element (TF)- targeting antibody-drug conjugate after co...
.3 weeks after Roche's Genentech unit walked away from an SHP2 inhibitor contract, Relay Therapeutic...
.Stoke Therapies' Dravet syndrome medicine has been actually devoid of a partial hold, getting rid o...
.Fierce Biotech Colleague Editor Gabrielle Masson offered the 2024 course of Ferocious 15 victors on...